Docetaxel and Carboplatin in Treating Patients With Metastatic, Castration Resistant Prostate Cancer Containing Inactivated Genes in the BRCA 1/2 Pathway

NCT02598895 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Castration Levels of Testosterone
Castration-Resistant Prostate Carcinoma
Metastatic Prostate Carcinoma
Prostate Carcinoma Metastatic in the Bone
PSA Progression
Stage IV Prostate Cancer

Interventions

DRUG: Carboplatin
DRUG: Docetaxel
OTHER: Laboratory Biomarker Analysis

Sponsor

University of Washington

Collaborators

[object Object]